Clinical trialObsCompleted
Examination of the Pancreas in New-onset Diabetes
Examination of the Pancreas in New-onset Diabetes (EXPAND Study)
- Outcome
- Finished, no results posted
- Phase
- Obs
- Status
- Completed
- Study type
- Observational
- Start
- May 2013
- Expected end
- 30 November 2016
- Enrollment
- 79 participants
- Sites
- 1
- Primary outcomes
- To create a prospective cohort of subjects with increased probability of being diagnosed with pancreatic cancer and identify pancreatic cancer in this cohort.
- Sponsor
- Other
- Results posted
- No
- Last update
- 7 November 2019
These are registry fields. A trial card, with population, design, endpoints and result direction each tied to a quote, is not in the data yet.
Ask this document
Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess.
Try
Source text
Brief summary public domain (ClinicalTrials.gov)
The purpose of this study is to create a prospective cohort of subjects with increased probability of being diagnosed with pancreatic cancer and then screen this cohort for pancreatic cancer
Detailed description public domain (ClinicalTrials.gov)
Compared to the general population, subjects \>50 years of age with new-onset diabetes (DM) are 8-times more likely to have pancreatic cancer (PaC). The likelihood of PaC in new-onset DM is further increased in those who have weight loss or elevated CA19-9. In this study patients with newly diagnosed diabetes will be prospectively identified. Those with weight loss and/or elevated pancreatic cancer marker (CA 19-9) will undergo pancreatic imaging. All subjects will be followed up to 24 months. If successful in identifying surgically removable PaC, this study will fundamentally change our practice and will be a major breakthrough in PaC treatment and research.
Intervention public domain (ClinicalTrials.gov)
Other: medical chart review. baseline, quarterly follow-up for 24 months
Intervention public domain (ClinicalTrials.gov)
Other: survey administration. baseline
Intervention public domain (ClinicalTrials.gov)
Other: Specimen collection. baseline
Primary outcome public domain (ClinicalTrials.gov)
To create a prospective cohort of subjects with increased probability of being diagnosed with pancreatic cancer and identify pancreatic cancer in this cohort.. We will prospectively identify patients with newly diagnosed diabetes and perform pancreatic imaging to identify pancreatic cancer Time frame: Follow subjects for 2 years..
Eligibility public domain (ClinicalTrials.gov)
Patient Characteristics: --Suspected or definite new-onset diabetes based on recent blood sugar and hemoglobin A1c values * No acute illness or steroid therapy * No prior pancreas surgery
Enrollment public domain (ClinicalTrials.gov)
Enrollment: 79 participants (actual).